Practical Considerations for the Use of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity: A Clinician-Oriented Guide-Uncorrected Proof
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2026 · 54 (54) · 11-11
DOI: 10.5543/tkd.2026.41542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2026. Verfasst von Gizem Tuğçe Alp und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alp, G. T., & Canpolat, A. G. (2026). Practical Considerations for the Use of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity: A Clinician-Oriented Guide-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 54(54), 11-11. https://doi.org/10.5543/tkd.2026.41542
Vancouver
Alp GT, Canpolat AG. Practical Considerations for the Use of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity: A Clinician-Oriented Guide-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2026;54(54):11-11. doi:10.5543/tkd.2026.41542
BibTeX
@article{Alp2026,
author = {Alp, Gizem Tuğçe and Canpolat, Asena Gökçay},
title = {Practical Considerations for the Use of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity: A Clinician-Oriented Guide-Uncorrected Proof},
journal = {Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology},
year = {2026},
volume = {54},
number = {54},
pages = {11--11},
doi = {10.5543/tkd.2026.41542}
}
EUVIMED